Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.

Heart rhythm - 1 Nov 2005

Fitzgerald Patrick T, Ackerman Michael J

Abstract excerpt

Drug-induced torsades de pointes (TdP) is a rare, but potentially lethal, unwanted effect of drugs, including many commonly prescribed noncardiac drugs. Despite its low frequency, drug-induced TdP has generated a great deal of angst among physicians and pharmaceutical companies as well as tragedy, albeit rare, among patients. Although in retrospect many patients who died suddenly as a result of drug-induced TdP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Fluoroquinolones
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Conduction System

Share to Pharmacogenetics

Share to Potassium Channels

Share to Risk Factors

Share to Torsades de Pointes

Source

Identifiers

PMID: 16253929
DOI: 10.1016/j.hrthm.2005.08.007

Genes

KCNH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.PMID 16253929Read ↗

Molecular predictors of drug-induced prolongation of the QT interval.Semantic proximity Read ↗

Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.Semantic proximity Read ↗

Acquired QT interval prolongation and HERG: implications for drug discovery and development.Semantic proximity Read ↗

QT interval prolongation and cardiac risk assessment for novel drugs.Semantic proximity Read ↗

Drug-induced arrhythmia: pharmacogenomic prescribing?Semantic proximity Read ↗

Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.Semantic proximity Read ↗

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Semantic proximity Read ↗

Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationSemantic proximity Read ↗

Drug‐ and non‐drug‐associated QT interval prolongationSemantic proximity Read ↗

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.Semantic proximity Read ↗

Pharmacogenomics and Acquired Long QT SyndromeSemantic proximity Read ↗

Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.